Reimagining the future of healthcare
Johnson & Johnson’s global head of external innovation, William ‘Bill’ Hait, describes innovation as often being “an overnight success you’ve worked on for many years”.
Hait began his career as a medical oncologist, spending almost 30 years in academia as chief of medical oncology at Yale, before starting the Rutgers Cancer Institute of New Jersey, which he led to receive the National Cancer Institute’s highest designation of Comprehensive Cancer Center in 2002.
He joined Johnson & Johnson in 2007, assumed the role of global therapy area head, oncology, in 2009 and led Janssen Research & Development from 2011 through to 2018.
• Read the article in full in pharmaphorum’s Deep Dive digital magazine